SO-22 Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study
Year: 2023
Type: conference-abstract
Source: Annals of Oncology
Institutions: University of Pisa, Azienda Ospedaliera Universitaria Pisana, University of Trento, Fondazione IRCCS Istituto Nazionale dei Tumori, Istituto Oncologico Veneto, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Institut Gustave Roussy, Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card. G. Panico", Azienda Ospedaliero-Universitaria Careggi, University of Florence, Ospedale San Bortolo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4382811474
